Therefore, the in vivo synergistic effect of high-dose BCG induced the downregulation of peripheral CD11b+/Gr-1+ MDSCs that was observed in the bladder cancer orthotopic model. The gene discussed is ITGAM; the disease is urinary bladder cancer.